AR026002A1 - Producto farmaceutico. - Google Patents

Producto farmaceutico.

Info

Publication number: AR026002A1
Authority: AR; Argentina
Prior art keywords: compound; formula; pharmaceutical products; pharmaceutical product; ceramide
Prior art date: 1999-10-14

Application number

ARP000105329A

Other languages

English (en)

Spanish (es)

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-14

Filing date

2000-10-10

Publication date

2002-12-26

2000-10-10 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2002-12-26 Publication of AR026002A1 publication Critical patent/AR026002A1/es

Links

239000000825 pharmaceutical preparation Substances 0.000 title abstract 4
229940127557 pharmaceutical product Drugs 0.000 title abstract 4
150000001875 compounds Chemical class 0.000 abstract 7
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 abstract 2
102000015696 Interleukins Human genes 0.000 abstract 2
108010063738 Interleukins Proteins 0.000 abstract 2
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 abstract 2
229940106189 ceramide Drugs 0.000 abstract 2
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 abstract 2
229940047122 interleukins Drugs 0.000 abstract 2
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 abstract 2
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
229910052794 bromium Inorganic materials 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
235000019155 vitamin A Nutrition 0.000 abstract 1
239000011719 vitamin A Substances 0.000 abstract 1
229940045997 vitamin a Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)

ARP000105329A 1999-10-14 2000-10-10 Producto farmaceutico. AR026002A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AT0173599A ATA173599A (de)	1999-10-14	1999-10-14	Pharmazeutisches produkt

Publications (1)

Publication Number	Publication Date
AR026002A1 true AR026002A1 (es)	2002-12-26

Family

ID=3519875

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP000105329A AR026002A1 (es)	1999-10-14	2000-10-10	Producto farmaceutico.

Country Status (6)

Country	Link
EP (1)	EP1220674A1 (de)
AR (1)	AR026002A1 (de)
AT (1)	ATA173599A (de)
AU (1)	AU7887800A (de)
CO (1)	CO5251422A1 (de)
WO (1)	WO2001026662A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN105473136A (zh) *	2013-04-18	2016-04-06	国家健康与医学研究院	用于在有此需要的受试者中抑制淋巴细胞增殖的方法和药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3010397A1 (de) *	1980-03-18	1981-10-29	Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen	Verwendung von 5-alkyl-pyrimidinnukleosiden als cytostatika
CA1295998C (en) *	1985-07-29	1992-02-18	Sai P. Sunkara	Nucleosides and their use as antineoplastic agents
TW466112B (en) *	1998-04-14	2001-12-01	Lilly Co Eli	Novel use of 2'-deoxy-2',2'-difluorocytidine for immunosuppressive therapy and pharmaceutical composition comprising the same

1999
- 1999-10-14 AT AT0173599A patent/ATA173599A/de not_active Application Discontinuation
2000
- 2000-10-10 AR ARP000105329A patent/AR026002A1/es unknown
- 2000-10-12 AU AU78878/00A patent/AU7887800A/en not_active Abandoned
- 2000-10-12 CO CO00077920A patent/CO5251422A1/es not_active Application Discontinuation
- 2000-10-12 WO PCT/AT2000/000265 patent/WO2001026662A1/de not_active Ceased
- 2000-10-12 EP EP00969051A patent/EP1220674A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
CO5251422A1 (es)	2003-02-28
ATA173599A (de)	2001-04-15
EP1220674A1 (de)	2002-07-10
WO2001026662A1 (de)	2001-04-19
AU7887800A (en)	2001-04-23

Similar Documents

Publication	Publication Date	Title
ES2061858T3 (es)	1994-12-16	Derivados sustituidos en posicion 7 del acido 3,5-dihidroxihept-6-inoico, procedimiento para su preparacion, su empleo como medicamentos, asi como productos intermedios.
MX9307779A (es)	1994-06-30	Compuestos benzoicos fundidos.
ES2144143T3 (es)	2000-06-01	Proceso de purificacion para productos de hexafluoroetano.
IT1098059B (it)	1985-08-31	Nuove preparazioni di microorganismi e procedimento per la loro produzione,come pure l'impiego delle stesse per la decomposizione di prodotti industriali organici di sintesi
NZ508924A (en)	2002-09-27	N-phenyl-1,2-dihydro-4-substituted-5-sulfursubstituted-1-alkyl-2-oxo-quinoline-3-carboxamide derivatives, and pharmaceuticals thereof
DK515489D0 (da)	1989-10-17	Dispergerbar laegemiddelformulering
TNSN87012A1 (fr)	1990-01-01	Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
AR019053A1 (es)	2001-12-26	Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen
HUT68547A (en)	1995-06-28	Acaricidal tetrazine-derivatives and process for production of the compounds
IL152337A0 (en)	2003-05-29	A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
MX19599A (es)	1994-04-29	Procedimiento para la preparacion de nuevos 19-nor-esteroides que tienen en posicion 11-beta una cadena carbonada que comprende una funcion amida o carbamato, productos obtenidos y composiciones farmaceuticas preparadas con el producto obtenido.
AR026002A1 (es)	2002-12-26	Producto farmaceutico.
ES2151743T3 (es)	2001-01-01	Procedimiento para la preparacion de n-((1-n-butil-4-piperidinil)metil)-3,4-dihidro-2h-(1,3)-oxazino(3,2-a)indol-10-carboxamida y las sales y productos intermedios en el procedimiento.
HUT41740A (en)	1987-05-28	Process for production of new medically effective imidasolidins and medical preparatives containing thereof
ES2172023T3 (es)	2002-09-16	Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CA2249756A1 (fr)	1999-04-03	Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ECSP003716A (es)	2001-05-23	Producto farmaceutico
HUP9801686A2 (hu)	1999-06-28	Amino-tetralin-származék alkalmazása kardiovaszkuláris megbetegedések terápiájában használható gyógyszer előállítására
IT1307786B1 (it)	2001-11-19	Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
FR2373285A1 (fr)	1978-07-07	Nouveaux derives du coenzyme b 12, procede de preparation et application a titre de medicaments de ces nouveaux produits
NO951350L (no)	1995-06-06	Farmasöytiske preparater inneholdende 3-substituerte 2-oksindol-1-karboksamider
DE3482324D1 (de)	1990-06-28	Verbindung mit entzuendungshemmender wirkung, verfahren zu ihrer herstellung und pharmazeutische praeparate die sie enthalten.
ITMI920560A0 (it)	1992-03-11	Procedimento per la preparazione di acido iodesossicolico ad elevata purezza per impiego farmaceutico
ES2071843T3 (es)	1995-07-01	Derivado de acido d-2-(6-metoxi-2-naftil)-propionico opticamente activo y composiciones farmaceuticas que lo contienen.
ES2132429T3 (es)	1999-08-16	Disacaridos de antraciclina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date	Code	Title	Description
2004-03-17	FB	Suspension of granting procedure